anti-CCR6 mAb (Monash University)

N/A

Report date: 2025/03/14 16:45:04

Base Information

Drug Nameanti-CCR6 mAb (Monash University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionC-C chemokine receptor type 6 inhibitors
TargetsC-C chemokine receptor type 6
Therapy Area/IndicationsAutoimmune DiseasesPsoriasisMultiple Sclerosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMonash University
China Registration ClassN/A

Develop Information

Active CompaniesMonash University
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesPsoriasisMultiple Sclerosis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A